Günay, S. et al. 2023. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 40, 3 (Sep. 2023), e2023029. DOI:https://doi.org/10.36141/svdld.v40i3.14418.